Regenerative Medicine Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Regenerative Medicine stocks.

Regenerative Medicine Stocks Recent News

Date Stock Title
Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
Nov 22 HUMA Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)
Nov 21 HUMA Insider Buyers At Humacyte Likely Disappointed With 17% Slide
Nov 21 HUMA Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery
Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
Nov 19 ABBV Where Will AbbVie Be in 5 Years?
Nov 19 LSTA Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’
Nov 19 ABBV RVPH: Year-End OLE Update
Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
Nov 18 ABBV AbbVie snaps eight straight sessions of losses
Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
Nov 18 ABBV Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
Nov 18 HUMA Humacyte Presents Preclinical Results of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting at American Heart Association’s Scientific Sessions 2024
Nov 18 ABBV AbbVie’s Elahere wins European approval for certain ovarian cancers
Regenerative Medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. If a regenerated organ's cells would be derived from the patient's own tissue or cells, this would potentially solve the problem of the shortage of organs available for donation, and the problem of organ transplant rejection.Some of the biomedical approaches within the field of regenerative medicine may involve the use of stem cells. Examples include the injection of stem cells or progenitor cells obtained through directed differentiation (cell therapies); the induction of regeneration by biologically active molecules administered alone or as a secretion by infused cells (immunomodulation therapy); and transplantation of in vitro grown organs and tissues (tissue engineering).

Browse All Tags